CVKD Cadrenal Therapeutics, Inc.: institutional ownership and insider trading
18 funds reported holding $760K of Cadrenal Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net bought $71.6K, with 5 new positions and 6 funds selling out; over the last 12 months insiders bought $0 and sold $501K on the open market.
CVKD revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$3.32M, EPS -1.14
- Quarter ended Mar 31, 2026: revenue n/a, net income −$2.50M, EPS -1.04
- Quarter ended Dec 31, 2025: revenue n/a, net income −$3.04M, EPS -1.37
- Quarter ended Sep 30, 2025: revenue n/a, net income −$2.69M, EPS -1.31
Largest institutional holders of CVKD
- VANGUARD GROUP INC — $366K
- VANGUARD CAPITAL MANAGEMENT LLC — $167K
- HRT FINANCIAL LP — $97.0K
- GEODE CAPITAL MANAGEMENT, LLC — $63.5K
- VANGUARD FIDUCIARY TRUST CO — $27.8K
- COURIER CAPITAL LLC — $21.4K
- Tower Research Capital LLC (TRC) — $4.28K
- UBS Group AG (UBS) — $3.71K
- MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) — $2.36K
- Clearstead Advisors, LLC — $2.17K
Recent CVKD insider trades
- Jun 29, 2026: Pham Quang X sold 7,400 shares ($22.4K)
- Jun 26, 2026: Pham Quang X sold 11,156 shares ($33.9K)
- Jun 23, 2026: Pham Quang X sold 11,444 shares ($39.8K)
- Jun 17, 2026: Pham Quang X sold 4,126 shares ($13.1K)
5%+ owners
- The PNC Financial Services Group, Inc.: 8.1% (Schedule 13G, filed Aug 7, 2026)
Who owns the most CVKD stock?
The largest institutional holders of Cadrenal Therapeutics, Inc. in the latest 13F filings are VANGUARD GROUP INC ($366K), VANGUARD CAPITAL MANAGEMENT LLC ($167K), HRT FINANCIAL LP ($97.0K).
Are insiders buying or selling CVKD?
Over the last 12 months insiders bought $0 and sold $501K of Cadrenal Therapeutics, Inc. stock on the open market (SEC Form 4).